These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 19401151)
1. The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor. Friedli A; Fischer E; Novak-Hofer I; Cohrs S; Ballmer-Hofer K; Schubiger PA; Schibli R; Grünberg J Int J Biochem Cell Biol; 2009 Jul; 41(7):1572-80. PubMed ID: 19401151 [TBL] [Abstract][Full Text] [Related]
2. Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2. Hall H; Hubbell JA Microvasc Res; 2004 Nov; 68(3):169-78. PubMed ID: 15501236 [TBL] [Abstract][Full Text] [Related]
3. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor. Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776 [TBL] [Abstract][Full Text] [Related]
4. Dual function of RGD-modified VEGI-192 for breast cancer treatment. Wu J; Jiang Y; Yang W; He Z; Meng S; Zhang Q; Lin M; Zhang H; Li W; Yang Y; Jia Y; Qian L; Lu D; Cai W; Luo G; Wang Y; Zhu X; Li M Bioconjug Chem; 2012 Apr; 23(4):796-804. PubMed ID: 22455451 [TBL] [Abstract][Full Text] [Related]
5. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation. Kwak HJ; Park MJ; Park CM; Moon SI; Yoo DH; Lee HC; Lee SH; Kim MS; Lee HW; Shin WS; Park IC; Rhee CH; Hong SI Int J Cancer; 2006 Jun; 118(11):2711-20. PubMed ID: 16388516 [TBL] [Abstract][Full Text] [Related]
6. Crosstalk between VEGF and novel angiogenic protein regulates tumor angiogenesis and contributes to aggressiveness of breast carcinoma. Belugali Nataraj N; Salimath BP Cell Signal; 2013 Jan; 25(1):277-94. PubMed ID: 23000338 [TBL] [Abstract][Full Text] [Related]
7. PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo. Tian F; Zhang X; Tong Y; Yi Y; Zhang S; Li L; Sun P; Lin L; Ding J Cancer Biol Ther; 2005 Aug; 4(8):874-82. PubMed ID: 16082187 [TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling. De Luisi A; Mangialardi G; Ria R; Acuto G; Ribatti D; Vacca A Eur Respir J; 2009 Oct; 34(4):958-66. PubMed ID: 19357149 [TBL] [Abstract][Full Text] [Related]
9. Porphyromonas gingivalis, periodontal pathogen, lipopolysaccharide induces angiogenesis via extracellular signal-regulated kinase 1/2 activation in human vascular endothelial cells. Koo TH; Jun HO; Bae SK; Kim SR; Moon CP; Jeong SK; Kim WS; Kim GC; Jang HO; Yun I; Kim KW; Bae MK Arch Pharm Res; 2007 Jan; 30(1):34-42. PubMed ID: 17328240 [TBL] [Abstract][Full Text] [Related]
10. Antibodies directed against L1-CAM synergize with Genistein in inhibiting growth and survival pathways in SKOV3ip human ovarian cancer cells. Novak-Hofer I; Cohrs S; Grünberg J; Friedli A; Schlatter MC; Pfeifer M; Altevogt P; Schubiger PA Cancer Lett; 2008 Mar; 261(2):193-204. PubMed ID: 18155830 [TBL] [Abstract][Full Text] [Related]
11. Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Arlt MJ; Novak-Hofer I; Gast D; Gschwend V; Moldenhauer G; Grünberg J; Honer M; Schubiger PA; Altevogt P; Krüger A Cancer Res; 2006 Jan; 66(2):936-43. PubMed ID: 16424028 [TBL] [Abstract][Full Text] [Related]
12. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo. Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383 [TBL] [Abstract][Full Text] [Related]
13. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Gutwein P; Stoeck A; Riedle S; Gast D; Runz S; Condon TP; Marmé A; Phong MC; Linderkamp O; Skorokhod A; Altevogt P Clin Cancer Res; 2005 Apr; 11(7):2492-501. PubMed ID: 15814625 [TBL] [Abstract][Full Text] [Related]
14. L1 Cell Adhesion Molecule and Its Soluble Form sL1 Exhibit Poor Prognosis in Primary Breast Cancer Patients. Wu JD; Hong CQ; Huang WH; Wei XL; Zhang F; Zhuang YX; Zhang YQ; Zhang GJ Clin Breast Cancer; 2018 Oct; 18(5):e851-e861. PubMed ID: 29510897 [TBL] [Abstract][Full Text] [Related]
15. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway. Jung MH; Lee SH; Ahn EM; Lee YM Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635 [TBL] [Abstract][Full Text] [Related]
16. Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis. Chavakis T; Cines DB; Rhee JS; Liang OD; Schubert U; Hammes HP; Higazi AA; Nawroth PP; Preissner KT; Bdeir K FASEB J; 2004 Aug; 18(11):1306-8. PubMed ID: 15208269 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways. Pan R; Dai Y; Gao XH; Lu D; Xia YF Vascul Pharmacol; 2011; 54(1-2):18-28. PubMed ID: 21078410 [TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic and pro-apoptotic effects of a small-molecule JFD-WS in in vitro and breast cancer xenograft mouse models. Rathinavelu A; Kanagasabai T; Dhandayuthapani S; Alhazzani K Oncol Rep; 2018 Apr; 39(4):1711-1724. PubMed ID: 29436685 [TBL] [Abstract][Full Text] [Related]